BackArtelo Biosciences Overview

Artelo Biosciences Long Term Debt

Artelo Biosciences's long-term debt is $7K.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$7000.00
86.27% YoYΔ $-44000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Artelo Biosciences Long Term Debt History

Loading

Artelo Biosciences vs. peers: Long Term Debt Comparison

Loading

Artelo Biosciences Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Artelo Biosciences (ARTL) FAQ

As of the most recent data (June 2026), ARTL shows a long-term debt of $7K. That compares with $51K in the prior-year period — down 86.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ARTL's long-term debt is now $7K (was $51K) — a 86.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Artelo Biosciences is outperforming or lagging.

Tracking ARTL's long-term debt over time shows whether Artelo Biosciences is scaling, shrinking, or reshaping that part of the business. The current reading is $7K That compares with $51K in the prior-year period — down 86.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this long-term debt page, Stockcircle has Artelo Biosciences's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect long-term debt (currently $7K) with ownership activity and broader fundamentals.

Artelo Biosciences's long-term debt is $7K; compare it with other Consumer Staples names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.